This topic contains a solution. Click here to go to the answer

Author Question: A chi-square test of independence with 10 degrees of freedom results in a test statistic of 19.25 . ... (Read 142 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
A chi-square test of independence with 10 degrees of freedom results in a test statistic of 19.25 . Using the chi-square table, the most accurate statement that can be made about the p-value for this test is that:
 a. p-value < 0.025
  b. 0.025 < p-value < 0.05
  c. 0.05 < p-value < 0.10
  d. 0.10 < p-value < 0.20
  e. p-value > 0.2

Question 2

The chi-square test of a contingency table is used to determine if there is enough evidence to infer that two nominal variables are related, and to infer that differences exist among two or more populations of nominal variables.
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

LVPMS

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

B

Answer to Question 2

T




LVPMS

  • Sr. Member
  • ****
  • Posts: 323

 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library